$0.8078
-0.096-10.62%
Últ. Act.: Nov 5, 7:47 PM
Biofrontera (BFRI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Biofrontera (BFRI) publicó su última previsión de enero 13, 2026 para fiscal year 2025. La compañía estimó ingresos en un rango de $41.5M - $42M para el período.
En comparación con la previsión anterior, Biofrontera elevado redujo su previsión de ingresos desde un rango anterior de $17M - $17.5M.
Biofrontera ha emitido 9 actualizaciones de orientación entre el noviembre 14, 2022 y el enero 13, 2026. During this period, the company raised its outlook 4 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.08 | $0.18 | $-0.58 |
| Actual | $-0.05 | $-0.41 | $0.48 | $-0.62 |
| Surprise | +28.6% | -412.5% | +166.7% | -6.90% |
| Revenue | ||||
| Estimate | $9.4M | $10.1M | $16.6M | $7.0M |
| Actual | $12.0M | $10.1M | $17.1M | $7.0M |
| Surprise | +27.7% | -0.16% | +2.99% | -0.17% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.15 | $0.28 |
| Revenue | ||
| Consensus | $8.2M | $15.8M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.05 | $-0.07 | 28.6 % |
| Q1 | May 14, 2026 | $-0.41 | $-0.08 | -412.5 % |
| Q4 | Mar 19, 2026 | $0.48 | $0.18 | 166.7 % |
| Q3 | Nov 12, 2025 | $-0.62 | $-0.58 | -6.90 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $12.00M | $9.40M | 27.7 % |
| Q1 | May 14, 2026 | $10.08M | $10.10M | -0.16 % |
| Q4 | Mar 19, 2026 | $17.10M | $16.60M | 2.99 % |
| Q3 | Nov 12, 2025 | $6.99M | $7.00M | -0.17 % |